Manalang, Jezamie A.

HRN: 28-93-94  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/08/2026
05/15/2026
IV
500mg
Q8H
Subdural And Subarachnoid Hemmorhage
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines